Document is current
Any future updates will be listed below
-
Authors
Potere, Nicola https://orcid.org/0000-0002-6585-4870
Giulianelli, Mattia
Candeloro, Matteo
Guglielmi, Maria Domenica
Pardi, Silvana
Di Nisio, Marcello
Porreca, Ettore
-
Funding
Funding for this research was provided by:
Università degli Studi G. D'Annunzio Chieti Pescara
- License Information
-
More Information
Article History
Received: 19 May 2025
Accepted: 24 September 2025
First Online: 7 October 2025
Declarations
:
: N.P. reports, outside of the present work, research fellowships and awards from the Italian Society for the Study on Thrombosis and Haemostasis, the International Society on Thrombosis and Haemostasis (ISTH) and the Canadian Venous Thromboembolism Research Network (CanVECTOR), and research funding, paid to his institution, from the International Network of VENous Thromboembolism Clinical Research Networks (INVENT) and the ISTH Scientific and Standardization Committee. M.D.N. reports, outside of the present work, personal fees as invited speaker from Bayer, Daiichi Sankyo, and Viatris, personal fees for advisory board membership from Leo Pharma and Pfizer, and institutional funding from Leo Pharma. The other authors have no conflicts of interest to disclose.
: The study was approved by the local institutional review board of the “G. d’Annunzio” University of Chieti–Pescara, Italy.
